NKCC1: Newly Found as a Human Disease-Causing Ion Transporter

Area of Science:

• Molecular Biology
• Human Genetics
• Physiology

Background:

• Electroneutral Na⁺-dependent chloride transporters, including NKCC2 and NCC, are known causes of Bartter and Gitelman syndromes.
• NKCC1, a related transporter, had not been previously linked to human diseases despite knockout mouse studies showing significant phenotypes.
• The identification of NKCC1 as a disease-causing protein has been a recent development in understanding human genetic disorders.

Purpose of the Study:

• To summarize recent clinical findings linking NKCC1 (SLC12A2) mutations to human diseases.
• To describe the spectrum of phenotypes associated with complete NKCC1 deficiency, dominant-negative mutations, and haploinsufficiency.

Main Methods:

• Clinical case studies of patients with inherited mutations in the NKCC1 transporter (SLC12A2).
• Analysis of genetic mutations, including complete absence of expression, dominant-negative alleles, and single-allele mutations.
• Phenotypic characterization of affected individuals, including audiological, neurological, and systemic assessments.

Main Results:

• Complete absence of NKCC1 expression in three children resulted in deafness, CFTR-like secretory defects, mucus accumulation, xerostomia, hypotonia, dysmorphic features, and severe neurodevelopmental disorder.
• A patient with a dominant-negative SLC12A2 mutation (premature stop codon) exhibited multi-system abnormalities (lung, bladder, intestine, pancreas, endocrine) but normal hearing and cognition.
• Haploinsufficiency of SLC12A2 due to single-allele mutations was associated with hearing loss and neurodevelopmental disorders.

Conclusions:

• NKCC1 is essential for normal development and function, and its absence or dysfunction leads to a range of severe human diseases.
• Mutations in SLC12A2 can cause distinct clinical phenotypes depending on the nature of the genetic defect (complete absence, dominant-negative effect, or haploinsufficiency).
• These findings highlight NKCC1's critical role in epithelial transport, hearing, and neurodevelopment, expanding the spectrum of SLC12A transporter-related disorders.